SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-30
👔
GYRE THERAPEUTICS, INC.
@GYRE_InsiderForm 4 Filing: Carmichael Gordon Acquires (Grant) shares of $GYRE
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
GYRE THERAPEUTICS, INC.
Ticker: $GYRE
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-10
Shares: 40,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Carmichael Gordon, holds the title of Director at GYRE THERAPEUTICS, INC..
On 2026-06-10, the insider transacted 40,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Carmichael Gordon (Director) was granted $0 of $GYRE
Post-Transaction Position: 40,000 shares
SEC Accession No: 0001140361-26-027008 (CIK: 1982077)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.